{
    "1, if you want to edit the results before saving. ": {
        "filled_form": {
            "hardware_4": "illumina novaseq 6000",
            "organism_part_5": "colon",
            "experimental_designs_10": "compound treatment design",
            "assay_by_molecule_14": "rna assay",
            "study_type_18": "rna-seq of coding rna"
        },
        "context": {
            "hardware_4": "37. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).  38. Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032\u20132034 (2015).  39. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an ef\ufb01cient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).\n...\nbased on their working mechanism to enable the analysis of their effect on the genomic landscape. Treatment related analyses were performed using combinations of the abbreviations mentioned above. For detailed information see Table 1.\n...\nwere mapped to GRCh38 using STAR (v2.6.1d)37. Sambamba (v0.7.0)38 was used to mark duplicates and index the resulting BAM \ufb01les. Gene annotation was derived from GENCODE Release 30 (https://www.gencodegenes.org/), raw read counts were obtained with feature- Counts (v1.6.3)39 and normalized using GeTMM40. Normalized data were used to (1) determine CMS with both the single-sample prediction parameter from the \u201cCMSclassi\ufb01er\u201d package (v1.0.0) (https://github.com/Sage-Bionetworks/ CMSclassi\ufb01er)2 and\n...\nto studies using either whole-exome sequencing (WES) or targeted sequencing of cancer-associated genes4\u20136. Although these studies yielded extensive knowledge on the presence of speci\ufb01c genomic aberrations in mCRC, they do not necessarily re\ufb02ect its complete molecular landscape. For optimal identi\ufb01cation of mutational signatures, the power pro- vided by whole-genome sequencing (WGS) data greatly exceeds that of WES7. Next to this, WGS simultaneously allows for the determination of MSI,\n...\n(ERBB2*) (CETN1*) (BCL2L1*) (KAT6A) (VWDE) (MET*) (PKD1L1) (no genes in peak) (no genes in peak) (hsa-mir-924*) (PARK2) (CDKN2A*) (WWOX) (CCSER1) (IRF2) (SMAD4) (NFATC1*) (STS*) (GPHN)  0.57  0.01 \u22120.02 0.13 \u22120.03 0.07 0.04  0.23 0.78 0.22  0.90 0.44 0.59 0.12  0.77  0.13  \u22120.78  \u22121.52  \u22121.35 \u22121.14  \u22120.21  \u22121.56  \u22123.30 \u22121.38 \u22121.88 \u22121.70  \u22123.30 \u22123.30  \u22121.14 1.19  17.65  2.79  2.66 1.78 2.79  \u22121.40  \u22121.10  3.68 3.59 3.04 3.59 1.64  1.78 \u22122.09",
            "organism_part_5": "References 1. Atlas, N. Comprehensive molecular characterization of human colon and  rectal cancer. Nature 487, 330\u2013337 (2012).\n...\nReceived: 30 June 2020; Accepted: 21 December 2020; Published online: 25 January 2021  28. Boulagnon-Rombi, C. et al. LRP1 expression in colon cancer predicts clinical outcome. Oncotarget 9, 8849 (2018).  29. Lupini, L. et al. Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients. BMC Cancer 15, 808 (2015).  References 1. Atlas, N. Comprehensive molecular characterization of human colon and\n...\nPrimary colorectal cancer (CRC) can be divided into a major  group of chromosomally instable tumors and a minor group of hypermutated, chromosomally stable tumors due to microsatellite instability (MSI) or POLE mutations1. Parallel to the described genomic subtype division, transcriptomic analysis was used to identify four consensus molecular subtypes (CMSs) with distinguishing features including prognosis2.\n...\n\u2709  email: s.wilting@erasmusmc.nl  NATURE COMMUNICATIONS | (2021)12:574 | https://doi.org/10.1038/s41467-020-20887-6 | www.nature.com/naturecommunications  1  ARTICLE  NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20887-6  Primary colorectal cancer (CRC) can be divided into a major\n...\n2. Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21, 1350\u20131356 (2015). Lech, G., Slotwinski, R., Slodkowski, M. & Krasnodebski, I. W. Colorectal cancer tumour markers and biomarkers: recent therapeutic advances. World J. Gastroenterol. 22, 1745\u20131755 (2016). Ishaque, N. et al. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer. Nat. Commun. 9, 4782 (2018).  3.",
            "experimental_designs_10": "based on their working mechanism to enable the analysis of their effect on the genomic landscape. Treatment related analyses were performed using combinations of the abbreviations mentioned above. For detailed information see Table 1.\n...\n37. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).  38. Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032\u20132034 (2015).  39. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an ef\ufb01cient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).\n...\n11. Chen, R., Sugiyama, A., Seno, H. & Sugimoto, M. Identi\ufb01cation of modules and functional analysis in CRC subtypes by integrated bioinformatics analysis. PLoS ONE 14, e0221772 (2019).  12. Menghi, F. et al. The tandem duplicator phenotype is a prevalent genome- wide cancer con\ufb01guration driven by distinct gene mutations. Cancer Cell 34 (197\u2013210), e195 (2018).  13. Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112\u2013121 (2020).\n...\nsignatures (DBS/SBS), driver genes (including non- coding genes), and GISTIC-de\ufb01ned CNVs. Items that reached univariate statistical signi\ufb01cance (p < 0.05) were used in a multi- variable penalized ordinal treatment response (Table 4).\n...\nKMT2D, and FAT1) were present in the Yaeger dataset of mCRC samples6. Mutations in all three overlapping genes were signi\ufb01cantly enriched in MSI cases (n = 16) compared to microsatellite stable (MSS) cases (n = 305) in this dataset as well (all Fisher p < =9.19E-7).",
            "assay_by_molecule_14": "RNA sequencing and CMS calling. Matched RNA was isolated from the same frozen tissue for 91 CRC patients on an automated setup (QiaSymphony) according to supplier\u2019s protocols (Qiagen) using the QIAsymphony RNA Kit for tissue and quanti\ufb01ed by Qubit. A total of 50\u2013100 ng of RNA was used as input for library preparation using the KAPA RNA HyperPrep Kit with RiboErase (Human/ Mouse/Rat) (Roche). Barcoded libraries were equimolarly pooled and sequenced using standard settings (Illumina) on either a\n...\n40. Smid, M. et al. Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons. BMC Bioinformatics. 19, 236 (2018).  14. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J. & Pandol\ufb01, P. P. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033\u20131038 (2010).\n...\nFor 91 cases RNA-seq data were available, allowing us to determine their Consensus Molecular Subtype (CMS). Remark- ably, using the CMS-classi\ufb01er package, none of the metastatic CRC samples were classi\ufb01ed as CMS3, whereas 10 were classi\ufb01ed as CMS1, 41 as CMS2, and 14 as CMS4. The remaining 26 samples (29%) could not be classi\ufb01ed into one of the 4 subtypes, which might be partly due to the presence of normal cells of noncolon origin in our metastatic setting. Indeed, using\n...\nThe remaining minor groups are found in Clusters 2, 4, and 5. Samples in clusters 2 and 4 are de\ufb01ned by a large contribution of labeled \u2018high TMB\u2019, DBS8 and DBS2, respectively. Cluster 5, contains 14 samples, which were all characterized by a high TMB (de\ufb01ned as >10/Mb) compared to only 82 out of the 415 remaining samples (20%) in the other clusters. High contribu- tions of DNA mismatch repair associated signatures SBS15/44 and DBS7 characterize the 13 MSI samples in this cluster,\n...\n37. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).  38. Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032\u20132034 (2015).  39. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an ef\ufb01cient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).",
            "study_type_18": "40. Smid, M. et al. Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons. BMC Bioinformatics. 19, 236 (2018).  14. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J. & Pandol\ufb01, P. P. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033\u20131038 (2010).\n...\n37. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).  38. Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032\u20132034 (2015).  39. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an ef\ufb01cient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).\n...\n35. Li, S. & Wu, X. Common fragile sites: protection and repair. Cell Biosci. 10, 1\u20139 (2020).  36. Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. L., Beroukhim, R. & Getz, G. GISTIC2.0 facilitates sensitive and con\ufb01dent localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).  37. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).\n...\nFor 91 cases RNA-seq data were available, allowing us to determine their Consensus Molecular Subtype (CMS). Remark- ably, using the CMS-classi\ufb01er package, none of the metastatic CRC samples were classi\ufb01ed as CMS3, whereas 10 were classi\ufb01ed as CMS1, 41 as CMS2, and 14 as CMS4. The remaining 26 samples (29%) could not be classi\ufb01ed into one of the 4 subtypes, which might be partly due to the presence of normal cells of noncolon origin in our metastatic setting. Indeed, using\n...\nRNA sequencing and CMS calling. Matched RNA was isolated from the same frozen tissue for 91 CRC patients on an automated setup (QiaSymphony) according to supplier\u2019s protocols (Qiagen) using the QIAsymphony RNA Kit for tissue and quanti\ufb01ed by Qubit. A total of 50\u2013100 ng of RNA was used as input for library preparation using the KAPA RNA HyperPrep Kit with RiboErase (Human/ Mouse/Rat) (Roche). Barcoded libraries were equimolarly pooled and sequenced using standard settings (Illumina) on either a"
        }
    }
}